GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) » Definitions » Other Long Term Assets

Hansoh Pharmaceutical Group Co (HKSE:03692) Other Long Term Assets : HK$749 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Hansoh Pharmaceutical Group Co Other Long Term Assets?

Hansoh Pharmaceutical Group Co's other long-term assets for the quarter that ended in Dec. 2023 was HK$749 Mil.

Hansoh Pharmaceutical Group Co's quarterly other long-term assets increased from Dec. 2022 (HK$730 Mil) to Jun. 2023 (HK$740 Mil) and increased from Jun. 2023 (HK$740 Mil) to Dec. 2023 (HK$749 Mil).

Hansoh Pharmaceutical Group Co's annual other long-term assets increased from Dec. 2021 (HK$484 Mil) to Dec. 2022 (HK$730 Mil) and increased from Dec. 2022 (HK$730 Mil) to Dec. 2023 (HK$749 Mil).

Hansoh Pharmaceutical Group Co Other Long Term Assets Historical Data

The historical data trend for Hansoh Pharmaceutical Group Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansoh Pharmaceutical Group Co Other Long Term Assets Chart

Hansoh Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial - 33.65 483.62 729.94 748.92

Hansoh Pharmaceutical Group Co Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 483.62 615.70 729.94 740.39 748.92

Hansoh Pharmaceutical Group Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Hansoh Pharmaceutical Group Co (HKSE:03692) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) » Definitions » Other Long Term Assets
Comparable Companies
HKSE:00867 HKSE:03320 HKSE:00570 HKSE:02096 HKSE:00512 HKSE:03933 HKSE:06185 HKSE:02005 HKSE:03613 HKSE:01349 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ NSE:DIVISLAB
Traded in Other Exchanges
3KY:Germany
Address
287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210
Website
https://www.hspharm.com
Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.

Hansoh Pharmaceutical Group Co (HKSE:03692) Headlines

No Headlines